Efficacy and safety of the immunomodulator spleen aminopeptide combined with bismuth in the treatment of Helicobacter pylori infection: A randomized controlled trial
The combination of spleen aminopeptide and bismuth quadruple therapy has a high eradication rate, fewer adverse events, and better immune function improvement.
Authors
- Wan-e ZHONG (ORCID: https://orcid.org/0009-0001-4384-5754)
- Lisha Luo (ORCID: https://orcid.org/0000-0002-1842-5782)
- Haifeng Zhang
- Ke Wang (ORCID: https://orcid.org/0000-0003-1487-190X)
- Yan Yang
- Ping Cao
Institutions
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
- Ningbo No. 2 Hospital (CN)
- Ningbo No.6 Hospital (CN)
Publication Details
- Journal
- Medicine
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1097/md.0000000000044911
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00